Search research articles
Contact Us
Filters
Showing results (21-30 of 52) with videos related to
Page
of 6
Sort By:
Acta Neuropathologica Communications
|
July 3, 2018
Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity
Asad Jan, Brandon Jansonius, Alberto Delaidelli, et al.
Acta Neuropathologica Communications
|
June 7, 2021
α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response
Alberto Delaidelli, Mette Richner, Lixiang Jiang, et al.
Cell Death and Differentiation
|
June 3, 2017
MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation
Alberto Delaidelli, Gian Luca Negri, Asad Jan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2024
Pharmacologic Inhibition of EIF4A Blocks NRF2 Synthesis to Prevent Osteosarcoma Metastasis
Michael M Lizardo, Christopher Hughes, Yue Z Huang, et al.
International Journal of Molecular Medicine
|
April 24, 2020
AMPK activation protects astrocytes from hypoxia‑induced cell death
Leli Barialai, Maja I Strecker, Anna-Luisa Luger, et al.
The Journal of Pathology
|
June 26, 2019
Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma
Gian Luca Negri, Bruno M Grande, Alberto Delaidelli, et al.
Cancer Immunology Research
|
May 16, 2019
Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
Shawn C Chafe, Paul C McDonald, Saeed Saberi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2021
Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study
Alberto Delaidelli, Christopher Dunham, Mariarita Santi, et al.
Neuro-Oncology
|
March 5, 2025
High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy resistant subgroups and MYC immunohistochemistry as a powerful outcome predictor
Alberto Delaidelli, Fares Burwag, Susana Ben-Neriah, et al.
Journal for Immunotherapy of Cancer
|
September 27, 2022
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
Jessica B Foster, Crystal Griffin, Jo Lynne Rokita, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 52) with videos related to
Sort By:
Page
of 6
Acta Neuropathologica Communications
|
July 3, 2018
Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity
Asad Jan, Brandon Jansonius, Alberto Delaidelli, et al.
Acta Neuropathologica Communications
|
June 7, 2021
α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response
Alberto Delaidelli, Mette Richner, Lixiang Jiang, et al.
Cell Death and Differentiation
|
June 3, 2017
MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation
Alberto Delaidelli, Gian Luca Negri, Asad Jan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2024
Pharmacologic Inhibition of EIF4A Blocks NRF2 Synthesis to Prevent Osteosarcoma Metastasis
Michael M Lizardo, Christopher Hughes, Yue Z Huang, et al.
International Journal of Molecular Medicine
|
April 24, 2020
AMPK activation protects astrocytes from hypoxia‑induced cell death
Leli Barialai, Maja I Strecker, Anna-Luisa Luger, et al.
The Journal of Pathology
|
June 26, 2019
Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma
Gian Luca Negri, Bruno M Grande, Alberto Delaidelli, et al.
Cancer Immunology Research
|
May 16, 2019
Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
Shawn C Chafe, Paul C McDonald, Saeed Saberi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2021
Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study
Alberto Delaidelli, Christopher Dunham, Mariarita Santi, et al.
Neuro-Oncology
|
March 5, 2025
High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy resistant subgroups and MYC immunohistochemistry as a powerful outcome predictor
Alberto Delaidelli, Fares Burwag, Susana Ben-Neriah, et al.
Journal for Immunotherapy of Cancer
|
September 27, 2022
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
Jessica B Foster, Crystal Griffin, Jo Lynne Rokita, et al.
Page
of 6